gsk glp 1 agonist Tanzeum (albiglutide) for Treatment of Type 2 Diabetes GLP-1 Receptor Agonist Shortage: Challenges
Description
These findings place GLP-1 receptor agonists among the most effective pharmacological strategies currently available for reducing cardiometabolic and renal risk in high-risk populations
However, discontinuation is often followed by partial weight regain within months, reinforcing that patients generally experience these medicines as chronic therapies rather than short term cures
Diagnostic accuracy of point-of-care gastric ultrasound
With insulin resistance, greater amounts of insulin are needed to maintain normal blood sugar levels
